MaxCyte (MXCT) Stock Chart & Stock Price History → The Only Energy Play You Should Be Looking At (From Wealthpin Pro) (Ad) Free MXCT Stock Alerts $4.48 -0.17 (-3.66%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends MaxCyte Stock Price Performance5 Day Performance-7.25%1 Month Performance+16.97%3 Month Performance-4.88%6 Month Performance-10.04%Year-To-Date Performance-4.68%1 Year Performance+2.52% Receive MXCT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MaxCyte and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyThis military-backed stock “owns” AI marketThe AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. MXCT Stock Chart for Sunday, June, 2, 2024 MXCT Chart by TradingView MaxCyte Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$4.65$4.48-3.66%$4.73$4.38325,157 shs$468.34 million05/30/2024$4.68$4.65-0.64%$4.72$4.60184,287 shs$486.11 million05/29/2024$4.83$4.68-3.11%$4.81$4.66258,427 shs$489.25 million05/28/2024$4.54$4.83+6.39%$4.86$4.45538,783 shs$504.93 million05/27/2024$4.54$4.54$4.61$4.44252,400 shs$474.61 million05/24/2024$4.54$4.54$4.61$4.44252,425 shs$474.61 million Get the Latest News and Ratings for MXCT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MaxCyte and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$4.60$4.54-1.30%$4.65$4.49225,073 shs$474.61 million05/22/2024$4.62$4.60-0.43%$4.85$4.53483,295 shs$480.90 million05/21/2024$4.75$4.62-2.74%$4.77$4.54298,121 shs$482.98 million05/20/2024$4.67$4.75+1.71%$4.78$4.61245,826 shs$496.57 million05/17/2024$4.80$4.67-2.71%$4.89$4.66271,236 shs$488.20 million05/16/2024$4.77$4.80+0.63%$4.88$4.73276,371 shs$501.79 million05/15/2024$4.54$4.77+5.07%$4.79$4.55352,512 shs$498.66 million05/14/2024$4.71$4.54-3.61%$4.83$4.54581,156 shs$474.61 million05/13/2024$4.74$4.71-0.63%$4.82$4.68194,079 shs$492.38 million05/10/2024$4.73$4.74+0.21%$4.79$4.60358,493 shs$495.54 million05/09/2024$4.64$4.73+1.94%$4.79$4.46896,063 shs$494.49 million05/08/2024$3.93$4.64+18.07%$5.13$3.942.82 million shs$485.08 million05/07/2024$3.91$3.93+0.51%$3.95$3.79315,268 shs$410.86 million05/06/2024$3.77$3.91+3.71%$3.92$3.78370,999 shs$408.75 million05/03/2024$3.83$3.77-1.57%$3.94$3.74477,677 shs$393.59 million05/02/2024$3.78$3.83+1.32%$3.85$3.62517,179 shs$399.84 million05/01/2024$3.63$3.78+4.13%$3.90$3.61651,319 shs$394.63 million04/30/2024$3.66$3.63-0.82%$3.71$3.57516,032 shs$378.97 million04/29/2024$3.71$3.66-1.35%$3.78$3.63341,756 shs$382.10 million04/26/2024$3.69$3.71+0.54%$3.74$3.59340,199 shs$387.32 million04/25/2024$3.74$3.69-1.34%$3.75$3.60429,334 shs$385.24 million04/24/2024$3.80$3.74-1.58%$3.80$3.67380,299 shs$390.46 million04/23/2024$3.96$3.80-4.04%$4.11$3.78569,042 shs$396.71 million04/22/2024$3.95$3.96+0.25%$3.97$3.87748,618 shs$413.42 million04/19/2024$3.88$3.95+1.80%$3.97$3.81534,108 shs$412.38 million04/18/2024$3.94$3.88-1.52%$3.94$3.82529,592 shs$405.06 million04/17/2024$3.99$3.94-1.25%$4.01$3.87825,008 shs$411.34 million04/16/2024$3.88$3.99+2.84%$4.01$3.82500,154 shs$416.56 million04/15/2024$4.00$3.88-3.00%$4.00$3.84279,668 shs$405.07 million04/12/2024$4.13$4.00-3.15%$4.15$4.00513,140 shs$417.60 million04/11/2024$4.09$4.13+0.98%$4.15$4.05284,871 shs$431.17 million04/10/2024$4.15$4.09-1.45%$4.18$4.08351,252 shs$427.00 million04/09/2024$4.14$4.15+0.24%$4.23$4.12269,214 shs$433.24 million04/08/2024$4.15$4.14-0.24%$4.20$4.10171,261 shs$432.22 millionThe Only Energy Play You Should Be Looking At (Ad)Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it.04/05/2024$4.12$4.15+0.73%$4.23$4.07285,152 shs$433.26 million04/04/2024$4.25$4.12-3.06%$4.27$4.10860,469 shs$428.88 million04/03/2024$4.11$4.25+3.41%$4.26$4.05608,689 shs$442.43 million04/02/2024$4.19$4.11-1.91%$4.22$4.07407,680 shs$427.85 million04/01/2024$4.19$4.19$4.21$4.05524,476 shs$436.18 million03/29/2024$4.19$4.19$4.34$4.16609,733 shs$436.17 million03/28/2024$4.32$4.19-3.01%$4.34$4.16609,632 shs$436.18 million03/27/2024$4.34$4.32-0.46%$4.50$4.22616,486 shs$449.71 million03/26/2024$4.35$4.34-0.23%$4.45$4.34417,734 shs$451.79 million03/25/2024$4.42$4.35-1.58%$4.46$4.31377,098 shs$452.84 million03/22/2024$4.51$4.42-2.00%$4.53$4.42499,561 shs$460.12 million03/21/2024$4.50$4.51+0.22%$4.61$4.44670,597 shs$469.49 million03/20/2024$4.46$4.50+0.90%$4.59$4.34485,669 shs$468.45 million03/19/2024$4.17$4.46+6.95%$4.56$4.07772,616 shs$464.27 million03/18/2024$4.31$4.17-3.25%$4.30$4.07560,885 shs$434.10 million03/15/2024$4.20$4.31+2.62%$4.39$4.15859,413 shs$448.67 million03/14/2024$4.16$4.20+0.96%$4.34$4.051.01 million shs$437.21 million03/13/2024$3.98$4.16+4.52%$4.41$3.981.10 million shs$433.06 million03/12/2024$3.97$3.98+0.25%$4.00$3.85907,197 shs$414.32 million03/11/2024$3.94$3.97+0.76%$4.06$3.94663,828 shs$413.28 million03/08/2024$4.02$3.94-1.99%$4.10$3.93475,086 shs$410.15 million03/07/2024$4.00$4.02+0.50%$4.05$3.97919,706 shs$418.48 million03/06/2024$4.10$4.00-2.44%$4.11$3.931.13 million shs$416.40 million03/05/2024$4.67$4.10-12.21%$4.63$4.03984,161 shs$426.44 million03/04/2024$4.71$4.67-0.85%$4.72$4.60284,272 shs$485.73 million03/01/2024$4.60$4.71+2.39%$4.80$4.56474,589 shs$489.89 million Related Companies: Heron Therapeutics Stock Price Chart MeiraGTx Stock Price Chart AnaptysBio Stock Price Chart National Research Stock Price Chart OmniAb Stock Price Chart Absci Stock Price Chart MacroGenics Stock Price Chart Harvard Bioscience Stock Price Chart Luna Innovations Stock Price Chart OneMedNet Stock Price Chart Receive MXCT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for MaxCyte and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MXCT) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaBiden replacement revealed?Paradigm PressBiden Nomination CANCELED?The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MaxCyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.